Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.0:1
Daily Buy & Sell Volume
Transactions (226)
Damora Therapeutics, Inc. (DMRA)
Winslow Garrett — General Counsel
Shares
245
Price
$29.98
Total Value
$7.35K
Shares Held After
2,289
% of Holdings
9.7%
NovaBridge Biosciences (NBP)
Xu Cong Claire — SVP, Clinical Development
Shares
4,485
Price
$0.89
Total Value
$3.99K
Shares Held After
298,101
% of Holdings
1.5%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
83,094
Price
$24.11
Total Value
$2.00M
Shares Held After
125,410
% of Holdings
39.9%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
8,506
Price
$13.96
Total Value
$118.74K
Shares Held After
146,305
% of Holdings
5.5%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
817
Price
$13.96
Total Value
$11.41K
Shares Held After
706,556
% of Holdings
0.1%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
10,000
Price
$38.00
Total Value
$380.00K
Shares Held After
2,700,000
% of Holdings
0.4%
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
17,400
Price
$8.50
Total Value
$147.90K
Shares Held After
1,393,653
% of Holdings
1.2%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
920
Price
$1.88
Total Value
$1.73K
Shares Held After
2,896
% of Holdings
24.1%
BICYCLE THERAPEUTICS PLC (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Shares
255
Price
$4.31
Total Value
$1.10K
Shares Held After
94,375
% of Holdings
0.3%
Sionna Therapeutics, Inc. (SION)
Fitzpatrick Jennifer — Chief Legal Officer
Shares
10,250
Price
$43.60
Total Value
$446.86K
Shares Held After
0
% of Holdings
100.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
400
Price
$24.13
Total Value
$9.65K
Shares Held After
67,845
% of Holdings
0.6%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
5,600
Price
$23.25
Total Value
$130.20K
Shares Held After
68,245
% of Holdings
7.6%
Cullinan Therapeutics, Inc. (CGEM)
Michaelson Jennifer — Chief Scientific Officer
Shares
8,000
Price
$17.82
Total Value
$142.56K
Shares Held After
162,844
% of Holdings
4.7%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
104
Price
$4.31
Total Value
$448.24
Shares Held After
64,441
% of Holdings
0.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
1,737
Price
$4.31
Total Value
$7.49K
Shares Held After
603,671
% of Holdings
0.3%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
333
Price
$4.34
Total Value
$1.45K
Shares Held After
91,052
% of Holdings
0.4%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
43
Price
$4.31
Total Value
$185.33
Shares Held After
91,385
% of Holdings
0.0%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
532
Price
$4.31
Total Value
$2.29K
Shares Held After
157,171
% of Holdings
0.3%
Hims & Hers Health, Inc. (HIMS)
Okupe Oluyemi — Chief Financial Officer
Shares
7,163
Price
$36.49
Total Value
$261.35K
Shares Held After
284,321
% of Holdings
2.5%
SOPHiA GENETICS SA (SOPH)
Verma Abhimanyu — Chief Technology Officer
Shares
5,285
Price
$5.10
Total Value
$26.96K
Shares Held After
192,171
% of Holdings
2.7%
DEXCOM INC (DXCM)
SAYER KEVIN R — Director
Shares
26,756
Price
$72.00
Total Value
$1.93M
Shares Held After
355,726
% of Holdings
7.0%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
22,486
Price
$5.25
Total Value
$118.16K
Shares Held After
3,558,807
% of Holdings
0.6%
Privia Health Group, Inc. (PRVA)
Morris Matthew Shawn — Director
Shares
53,722
Price
$27.24
Total Value
$1.46M
Shares Held After
68,188
% of Holdings
44.1%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
7,393
Price
$5.16
Total Value
$38.16K
Shares Held After
233,387
% of Holdings
3.1%
SOPHiA GENETICS SA (SOPH)
Puylaert Kevin — Chief Sales Officer
Shares
31
Price
$5.09
Total Value
$157.67
Shares Held After
147,948
% of Holdings
0.0%
SOPHiA GENETICS SA (SOPH)
Puylaert Kevin — Chief Sales Officer
Shares
47
Price
$5.03
Total Value
$236.18
Shares Held After
147,979
% of Holdings
0.0%
SOPHiA GENETICS SA (SOPH)
Puylaert Kevin — Chief Sales Officer
Shares
138
Price
$5.03
Total Value
$693.46
Shares Held After
148,026
% of Holdings
0.1%
SOPHiA GENETICS SA (SOPH)
Valente Manuela — Chief People Officer
Shares
4,241
Price
$5.05
Total Value
$21.43K
Shares Held After
210,450
% of Holdings
2.0%
SOPHiA GENETICS SA (SOPH)
CARDOZA GEORGE — Chief Financial Officer
Shares
1,592
Price
$5.29
Total Value
$8.42K
Shares Held After
309,092
% of Holdings
0.5%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
7,393
Price
$5.17
Total Value
$38.24K
Shares Held After
614,887
% of Holdings
1.2%
SOPHiA GENETICS SA (SOPH)
Muken Ross — Director
Shares
9,838
Price
$5.22
Total Value
$51.35K
Shares Held After
670,651
% of Holdings
1.4%
Phreesia, Inc. (PHR)
Hui Yvonne — Principal Accounting Officer
Shares
1,371
Price
$10.84
Total Value
$14.86K
Shares Held After
23,908
% of Holdings
5.4%
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
HRT FINANCIAL LP — 10% Owner
Shares
9,022
Price
$3.51
Total Value
$31.67K
Shares Held After
81,385
% of Holdings
10.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
306
Price
$553.90
Total Value
$169.49K
Shares Held After
40,513
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
135
Price
$553.39
Total Value
$74.71K
Shares Held After
40,819
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
131
Price
$551.88
Total Value
$72.30K
Shares Held After
40,954
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
329
Price
$550.78
Total Value
$181.21K
Shares Held After
41,085
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,116
Price
$549.87
Total Value
$1.16M
Shares Held After
41,414
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,354
Price
$549.03
Total Value
$1.84M
Shares Held After
43,530
% of Holdings
7.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,031
Price
$548.00
Total Value
$564.99K
Shares Held After
46,884
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,098
Price
$546.93
Total Value
$1.15M
Shares Held After
47,915
% of Holdings
4.2%
HEALTHSTREAM INC (HSTM)
REBROVICK LINDA — Director
Shares
6,000
Price
$29.00
Total Value
$174.00K
Shares Held After
51,329
% of Holdings
10.5%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
2,270
Price
$14.00
Total Value
$31.78K
Shares Held After
90,180
% of Holdings
2.5%
Sight Sciences, Inc. (SGHT)
HAYDEN JEREMY B. — Chief Legal Officer
Shares
12,733
Price
$5.51
Total Value
$70.13K
Shares Held After
357,037
% of Holdings
3.4%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
2,087
Price
$57.76
Total Value
$120.55K
Shares Held After
104,395
% of Holdings
2.0%
Sight Sciences, Inc. (SGHT)
Badawi David — Director
Shares
7,418
Price
$5.51
Total Value
$40.86K
Shares Held After
1,982,872
% of Holdings
0.4%
Vaxcyte, Inc. (PCVX)
GUGGENHIME ANDREW — PRESIDENT AND CFO
Shares
7,913
Price
$57.16
Total Value
$452.28K
Shares Held After
106,482
% of Holdings
6.9%
Teladoc Health, Inc. (TDOC)
Bliss Kelly — President, U.S. Group Health
Shares
2,500
Price
$9.50
Total Value
$23.75K
Shares Held After
84,878
% of Holdings
2.9%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Reynoso Jamie L. — CEO, Medicare Advantage
Shares
6,229
Price
$5.26
Total Value
$32.76K
Shares Held After
2,834,982
% of Holdings
0.2%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$54.03
Total Value
$109.90K
Shares Held After
227,490
% of Holdings
0.9%
Showing 101–150 of 226 transactions (page 3 of 5)